Archives for May 17, 2005

← 2005

Linker peptide joins drugs to devices

Engineers in the US have found a way to modify a plastic so that it can anchor molecules that promote nerve regeneration, blood vessel growth or other biological processes.

MedImmune presents positive MAb data

MedImmune has announced Phase I clinical trial results of an antibody that appeared to be safe and well tolerated in patients with certain T-cell lymphomas and leukemias. The results signify the emergence of monoclonal antibodies (MAb) as viable and...

Small-volume sampler from NovAseptic

NovAseptic has launched a low volume product in its NovaSeptum range of sterile disposable sampling systems, to cater for what it says is the growing requirement for small, accurate volume sampling in the drug industry.

GS identifies strong 2005 osteoporosis pipeline

Osteoporosis, which has developed into a multibillion-dollar market, and is dominated by Merck's Fosamax and Proctor & Gamble/Sanofi-Aventis' Actonel, now faces new competition after the Food and Drug Administration (FDA) approved new treatments that...

ArQule reports anti-tumour efficacy at ASCO

Biotechnology company, ArQule, have reported evidence of anti-tumour activity of its drug candidate that has a mechanism of action based on its Activated Checkpoint Therapy (ACT) platform and represents the latest monotherapeutic strategy to treat cancer.

Wireless effusivity sensor launched by Mathis

Mathis Instruments has introduced a wireless version of its effusivity sensor - the ESP - that is suitable for use in pharmaceutical production settings, reports Phil Taylor.

Qiagen enters protein glycoanalysis deal

Qiagen and Procognia have entered into a marketing and licensing agreement, which targets the emerging field of protein glycoanalysis. The combination of Qproteome products with Procognia's On-Chip Glycoanalysis technology aims to create a host of...